This study shows that Lactobacillus reuteri Prodentis is effective in both the treatment and prevention of dental implant diseases and will support the growth of BioGaia’s business in dental ...

BioGaia (STO:BIOGB) A double-blind, randomised, placebo-controlled study in 45 women with pregnancy gingivitis showed that supplementation of L. reuteri Prodentis significantly reduced ...

The company's focus on innovation and product launches, such as the BioGaia Gastro Pure Action capsule and Prodentis Mint lozenges, contributed to its growth. The transition to a direct business ...

Has signed an agreement with BioWellTech Co Ltd for the rights to sell BioGaia ProDentis in Hong Kong. * The launch is planned to take place during the third quarter of 2016. Source text for Eikon ...